1387566-92-8

Basic information

• Product Name: 3-[(4-chloro-2-fluorophenyl)amino]-1,4-dioxo-1,4-dihydronaphthalene-2-carboxylic acid
• Synonyms: 3-[(4-chloro-2-fluorophenyl)amino]-1,4-dioxo-1,4-dihydronaphthalene-2-carboxylic acid
• CAS NO: 1387566-92-8
• Molecular Weight: 345.714
• Mol File: 1387566-92-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 3-[(4-chloro-2-fluorophenyl)amino]-1,4-dioxo-1,4-dihydronaphthalene-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(4-chloro-2-fluorophenyl)amino]-1,4-dioxo-1,4-dihydronaphthalene-2-carboxylic acid(1387566-92-8)
• EPA Substance Registry System: 3-[(4-chloro-2-fluorophenyl)amino]-1,4-dioxo-1,4-dihydronaphthalene-2-carboxylic acid(1387566-92-8)

Safety Data

• Hazardous Substances Data: 1387566-92-8(Hazardous Substances Data)

Upstream product

• 57946-56-2 2-fluoro-4-chloroaniline 
• 31519-22-9 1,4-dihydroxy-2-naphthoic acid 

Relevant articles and documents

A laccase-catalysed one-pot synthesis of aminonaphthoquinones and their anticancer activity

Nuclear monoamination of a 1,4-naphthohydroquinone with primary aromatic amines was catalysed by the commercial laccase, Novozym 51003, from Novozymes to afford aminonaphthoquinones. The synthesis was accomplished by reacting a mixture of the primary amine and 1,4-naphthohydroquinone in succinate-lactate buffer and a co-solvent, dimethylformamide, under mild reaction conditions in a vessel open to air at pH 4.5 and pH 6.0. Anticancer screening showed that the aminonaphthoquinones exhibited potent cytostatic effects particularly against the UACC62 (melanoma) cancer cell line (GI50 = 3.98-7.54 μM). One compound exhibited potent cytostatic effects against both the TK10 (renal) and the UACC62 (melanoma) cancer cell line. The cytostatic effects of this compound (GI50 = 8.38 μM) against the TK10 cell line was almost as good as that of the anticancer agent, etoposide (GI50 = 7.19 μM). Two compounds exhibited potent cytostatic effects against both the UACC62 (melanoma) and the MCF7 (breast) cancer cell lines. The total growth inhibition (TGI) of most of the compounds was better than that of etoposide against the UACC62 cell line. Three compounds (TGI = 7.17-7.94 μM) exhibited potent cytostatic effects against the UACC62 cell line which was 7 to 8-fold better than that of etoposide (TGI = 52.71 μM). The results are encouraging for further study of the aminonaphthoquinones for potential application in anticancer therapy.